Companies category powered by

IMER Cyprus: CAR-T cancer treatment may be administered out-patient

IMER medical services has announced that the Israeli CAR-T cancer treatment could be administered out-patient – which would be a first in world.

The therapy was developed at Hadassah University Hospital to treat Multiple Myeloma, AL Amyloidosis and other BCMA-positive malignancies.

Prof Polina Stepensky, Dr Shlomit Kfir-Erenfeld and Dr Nathalie Asherie of Hadassah’s Bone Marrow Transplantation Department, in collaboration with Prof Cyrille J. Cohen of Bar-Ilan University, developed the CAR-T treatment for myeloma.

Chimeric antigen receptor T-cell therapy is a treatment in which a patient’s T-cells are altered in a lab to attack cancer cells. Myeloma, AL amyloidosis and BCMA-positive malignancies are all types of blood cancers. The first two are generally found in the bone marrow.

iMER (International Medical Evaluation and Referrals) is a Worldwide Health Services Provider and the exclusive representative of Hadassah University Hospital in Greece and Cyprus since March 2007, with offices in Cyprus (Nicosia and Limassol) and Israel (in Hadassah hospital).

Read More

Harris Kyriakides examines key legal issues facing insurance companies
TITAN Group invests in sustainable construction materials platform in the UK
Cyprus-based Outfit7 announces new games, new audiences, and new Talking Tom
13th Invest Cyprus International Investment Awards almost here
This is what Larnaca and Paphos airports will look like after completion of Phase II works (video)
Theo Parperis on how establishing Cyprus as one of the region's family office hubs will increase FDI
HHG strengthens presence in Cyprus with acquisition of Evangelismos Private Hospital in Paphos
AMC Signature Quotes: An act of social contribution by the American Medical Center
TechIsland launches new professional initiative for the Legal Community
Paphos gets a security upgrade: Fortsafe brings global standards to Cyprus